Halozyme Therapeutics shares owned by Winton Capital
Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Winton Capital
from 13F filings
Historical chart of Winton Capital investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by Winton Capital consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Halozyme Therapeutics by Winton Capital
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $6.0M | 148k | 40.68 |
| 2023-03-31 | $651k | 17k | 38.19 |
| 2022-03-31 | $5.0M | 125k | 39.88 |
| 2021-12-31 | $8.1M | 201k | 40.21 |
| 2021-09-30 | $1.7M | 42k | 40.68 |
| 2021-06-30 | $2.2M | 49k | 45.41 |
| 2021-03-31 | $1.9M | 46k | 41.68 |
| 2020-12-31 | $2.1M | 49k | 42.71 |
| 2020-09-30 | $5.3M | 202k | 26.28 |
| 2020-06-30 | $2.6M | 96k | 26.81 |
| 2020-03-31 | $1.5M | 85k | 17.99 |
| 2019-12-31 | $1.8M | 100k | 17.73 |
| 2019-09-30 | $316k | 20k | 15.49 |